-
Research
-
Media Coverage
In the Spotlight
NIH Project Aims to Make Gene Therapy ‘Playbook’ Public
MedPage Today, LLC ∙ 01/18/2023 ∙ Bespoke Gene Therapy Consortium, ∙ Rare Diseases
As more families raise money for and partner with researchers to develop tailored, personalized treatments for rare diseases, some NIH agencies are trying to help by streamlining the process.
The PaVe-GT program aims not only to blaze a path forward in advancing gene therapy for four rare diseases, but to share its “playbook” for doing so publicly -- including often-proprietary information on manufacturing and FDA filings.
March 2023
-
Virpax Pharmaceuticals Reports 2022 Year-End Results
Associated Press ∙ 03/22/2023 ∙ NCATS -
Liver Cancer Finding May Lead to New Class of Antitumor Therapies
Genetic Engineering & Biotechnology News ∙ 03/16/2023 ∙ Division of Preclinical Innovation -
New Law the Beginning of the End of Animal Research?
Medscape ∙ 03/16/2023 ∙ Tissue Chip -
This NIH Center Has Brought 44 Drugs for Rare Diseases to Market — and Isn't Slowing Down
Becker's Hospital Review ∙ 03/16/2023 ∙ Division of Preclinical Innovation, NCATS -
Manatt Supports Launch of NCATS Alliance Alongside Leading Health Care Organizations
Manatt ∙ 03/15/2023 ∙ NCATS -
40% Higher Risk: New Study Finds Connection Between Discrimination and Dementia
SciTechDaily ∙ 03/14/2023 ∙ CTSA Program -
Specific Enzyme Produced in Liver Cancer Cells Could Turn a Molecule Into Potential Anticancer Drug
News-Medical.net ∙ 03/14/2023 ∙ Division of Preclinical Innovation -
Take Risk Into Account Before Repeat Surveillance Colonoscopy, Study Says
MedPage Today, LLC ∙ 03/14/2023 ∙ CTSA Program -
Old Drugs, New Uses: Advances in Drug Repurposing and the Federal Outlook
The Pharma Letter ∙ 03/14/2023 ∙ BrIDGs, Division of Preclinical Innovation, New Therapeutic Uses, TRND -
NASA, SpaceX Dragon to Deliver Heart Studies, More to Space Station
Associated Press ∙ 03/14/2023 ∙ Tissue Chip -
How Can You Overcome Diuretic Resistance in Patients With Heart Failure
Clinical Correlations ∙ 03/13/2023 ∙ Division of Preclinical Innovation -
The NCATS Alliance: Speeding the Process of Bringing New Treatments to Patients
Manatt ∙ 03/11/2023 ∙ NCATS -
Could Default Eligibility Improve Clinical Trial Enrolment?
European Pharmaceutical Review ∙ 03/09/2023 ∙ CTSA Program -
Cognitive Remediation Training Reduces Aggression in Schizophrenia
MDedge Psychiatry ∙ 03/09/2023 ∙ CTSA Program -
Heart Muscle Tissue Chips Among Life Science Investigations Launching to ISS on SpaceX CRS-27
Associated Press ∙ 03/08/2023 ∙ Tissue Chip -
FDA Mandate on Acetaminophen-Opioid Combinations Appeared Effective
TechiLive.in ∙ 03/08/2023 ∙ CTSA Program -
FDA’s Acetaminophen Limit Linked With Reduced Serious Liver Injury
SciTechDaily ∙ 03/07/2023 ∙ CTSA Program -
FDA Mandate on Acetaminophen-Opioid Combinations Appeared Effective
MedPage Today, LLC ∙ 03/07/2023 ∙ CTSA Program -
Next SpaceX Mission to International Space Station Includes Research on Cardiac Tissue Chips, Protein Crystals, and Materials for Cost-Effective Satellites
Associated Press ∙ 03/07/2023 ∙ Tissue Chip -
Expanding ICD Codes May Aid Rare Disease Patients, Research
MedPage Today, LLC ∙ 03/02/2023 ∙ Rare Diseases -
Toxic Protein Linked to Muscular Dystrophy, Rare Facial Malformation
eGreenews ∙ 03/02/2023 ∙ Rare Diseases
February 2023
-
New Harmful Effects of Vaping: Study Finds Lung Inflammation Worse in E-Cigarette Users Than Smokers
SciTechDaily ∙ 02/28/2023 ∙ CTSA Program -
SpaceX Crew-6 Astronauts Will Answer 'Burning Questions' With Space Station Science
Space.com ∙ 02/25/2023 ∙ Tissue Chip -
Sublingual Immunotherapy Appears Viable in Treating Peanut Allergies in Kids
MedPage Today, LLC ∙ 02/24/2023 ∙ CTSA Program -
What is Spillover? Bird Flu Outbreak Underscores Need for Early Detection to Prevent the Next Big Pandemic
Yahoo! News ∙ 02/24/2023 ∙ CTSA Program -
Higher Dose of Ivermectin, and for Longer, Still No Help Against COVID
TechiLive.in ∙ 02/23/2023 ∙ CTSA Program -
FAMILY PET Imaging of Hepatocellular Carcinoma
Pet News 2Day ∙ 02/22/2023 ∙ CTSA Program -
Oxygen Therapy Found to Ameliorate Abnormal Movements in a Rare Childhood Disease
Medical Xpress ∙ 02/20/2023 ∙ Rare Diseases -
COVID-19 Vaccination Can Reduce Cardiovascular Risk Post-Infection, Study Finds
HCPLive ∙ 02/20/2023 ∙ CTSA Program -
When Science Isn’t Moving Fast Enough To Cure Your Child
Galaxy Concerns ∙ 02/19/2023 ∙ Rare Diseases -
Variations in Long COVID Symptoms and Diagnostic Experiences Among Racial, Ethnic Groups
News-Medical.net ∙ 02/16/2023 ∙ CTSA Program -
Progress Report: Pharma Adoption of Data Analytics
Applied Clinical Trials ∙ 02/16/2023 ∙ CTSA Program -
New $1 Test is a Better Way to Detect COVID
Futurity ∙ 02/16/2023 ∙ CTSA Program -
Do Repeat COVID Infections Increase the Risk of Severe Disease or Long COVID?
Scientific American ∙ 02/15/2023 ∙ NCATS -
Rare Disease Day 2023 at the NIH
CheckRare ∙ 02/14/2023 ∙ Rare Diseases -
No Negative Neurodevelopmental Issues With Late Exposure to Antenatal Steroids
MedPage Today, LLC ∙ 02/12/2023 ∙ NCATS -
Researchers Show That Paxlovid Remains Highly Effective on Omicron Variants
NewsATW ∙ 02/11/2023 ∙ CTSA Program -
Researchers Identify Underreported Symptoms in Patients With Common Form of Genetic Epilepsy
Mirage News ∙ 02/10/2023 ∙ CTSA Program -
Phthalates Up Type 2 Diabetes Risk in Midlife White Women
Medscape ∙ 02/10/2023 ∙ CTSA Program -
Common Plastics Chemical Tied to Higher Diabetes Risk in Women
U.S. News & World Report ∙ 02/09/2023 ∙ CTSA Program -
Self-Fulfilling Prophecy: When Physicians Associate Race and Culture With Poor Health Outcomes
Elsevier ∙ 02/09/2023 ∙ CTSA Program -
Ladies, Watch What You Eat – Study Says Phthalates Intake May Raise Diabetes Risk
TIMES NOW ∙ 02/09/2023 ∙ CTSA Program -
Septic Shock Linked to 'Surprisingly High' Mortality Rate Among Patients With Solid Tumors
KNOWLEDIA ∙ 02/09/2023 ∙ NCATS -
Hillstream BioPharma Announces Acceptance of Abstract at AACR 2023 Annual Meeting Highlighting HSB-510 as Novel Bi-Functional Inhibitor for Solid Tumors & Leukemias
Yahoo! Finance ∙ 02/08/2023 ∙ NCATS -
Injured Black Children Are Over-Reported as Abuse Victims
Futurity ∙ 02/08/2023 ∙ CTSA Program -
Just a Teaspoon: Adding Herbs and Spices to Your Diet Could Improve Gut Health
SciTechDaily ∙ 02/07/2023 ∙ CTSA Program -
Financial Coaching for Parents in Clinic Leads to Higher Attendance at Well-Child Health Care Visits for Their Young Children
ReachMD ∙ 02/03/2023 ∙ CTSA Program -
Ex Vivo vs In Vivo Gene Therapy
CheckRare ∙ 02/02/2023 ∙ Bespoke Gene Therapy Consortium -
Experts Outline NIH's COVID-19 Research Response
News-Medical.net ∙ 02/02/2023 ∙ NCATS -
Acute Hepatic Porphyrias Not as Rare as Previously Thought
Medscape ∙ 02/01/2023 ∙ RDCRN
January 2023
-
How New Platforms Are Shaping the Future of Preclinical Research
Medium ∙ 01/31/2023 ∙ Tissue Chip -
Virpax Pharmaceuticals Engages New England Investors to Direct Licensing Strategy for Envelta™ in China
Yahoo! ∙ 01/31/2023 ∙ NCATS -
Oral Intradialytic Amino Acid Supplementation to Vitalize End-Stage Kidney Disease Patients on Hemodialysis
TrialBulletin.com ∙ 01/30/2023 ∙ NCATS -
Symptoms of Huntington's Disease You Shouldn't Ignore
NewsBreak ∙ 01/30/2023 ∙ GARD -
Acute Hepatic Porphyrias No Longer As Rare As Previously Thought
MDedge Internal Medicine ∙ 01/30/2023 ∙ RDCRN -
A Natural Non-Invasive Neurotechnology Improves Sleep and Well-Being in a Randomized, Controlled Clinical Trial
News Times Nigeria ∙ 01/28/2023 ∙ CTSA Program -
Reversing Osteoporosis - With A Pill: FIU Scientists Pinpoint a New Method to Help Bone-Producing Cells Make More Bone
South Florida Sun Times ∙ 01/26/2023 ∙ Division of Preclinical Innovation -
Myasthenia Gravis and Vision
CheckRare ∙ 01/25/2023 ∙ RDCRN -
Cell Culture – Good Practice and Advanced Methods
Technology Networks ∙ 01/24/2023 ∙ Division of Preclinical Innovation -
Tips to Belong to the Rare Diseases Clinical Research Network (RDCRN)
CheckRare ∙ 01/24/2023 ∙ RDCRN -
New Approaches to Macular Degeneration: Test Tube Retinas
Forbes ∙ 01/24/2023 ∙ 3-D Modeling -
Researchers Pinpoint New Method to Help Bone-Producing Cells Make More Bone
Phys.org ∙ 01/23/2023 ∙ NCATS -
Do Footballers Age Faster?
Industry Update ∙ 01/22/2023 ∙ CTSA Program -
'I Thought I Had Woken Up to an Earthquake': What We Heard This Week
MedPage Today, LLC ∙ 01/22/2023 ∙ Bespoke Gene Therapy Consortium, Rare Diseases -
The FDA Failed – Banning Fruity Flavors Did Not Stop Vaping
TechnoBlender ∙ 01/20/2023 ∙ CTSA Program -
Exploring the Intersection of Structural Racism and Ageism in Healthcare
Medscape ∙ 01/19/2023 ∙ CTSA Program -
Why Is Finding New Indications for Existing Drugs So Important?
Healthcare Economist ∙ 01/19/2023 ∙ New Therapeutic Uses -
Datavant Secures FedRAMP® Authorization, Trusted by Federal Agencies Through Privacy-Preserving Infrastructure
Yahoo! Finance ∙ 01/18/2023 ∙ CTSA Program -
Coffin-Siris Syndrome: Symptoms and Outlook
Medical News Today ∙ 01/18/2023 ∙ GARD -
Ovarian Cancer May Be Linked to Pathogenic Microbe Colonization in Reproductive Tract
The ASCO Post ∙ 01/18/2023 ∙ CTSA Program -
NIH Project Aims to Make Gene Therapy ‘Playbook’ Public
MedPage Today, LLC ∙ 01/18/2023 ∙ Bespoke Gene Therapy Consortium, Rare Diseases -
What Are New Chemical Entities (NCE)?
AZoLifeSciences.com ∙ 01/17/2023 ∙ NCATS -
Animal Testing No Longer Required for Drug Approval. But High-Tech Substitutes Aren't Ready.
USA TODAY ∙ 01/15/2023 ∙ Tissue Chip -
Fluvoxamine Flops Again for Milder COVID-19: Large Platform Trial Continues the Drug's Losing Streak
MedPage Today, LLC ∙ 01/12/2023 ∙ CTSA Program -
COVID-19 Convalescent Plasma Fails to Improve Clinical Outcomes Among Hospitalized Patients
Healio ∙ 01/11/2023 ∙ CTSA Program -
From COVID to Gut Microbiome: How Wastewater Can Be Used to Monitor Human Well-Being
Memesita ∙ 01/10/2023 ∙ CTSA Program -
New 3-D Model Offers Insights Into the Role of Glucose in a Deadly Kidney Disease
Technology.org ∙ 01/09/2023 ∙ 3-D Modeling, Division of Preclinical Innovation -
Pro-Inflammatory Alterations of Circulating Monocytes in Latent Tuberculosis Infection
Head Topics ∙ 01/06/2023 ∙ CTSA Program -
Epidemiology and Trends in Stroke Mortality in the USA, 1975–2019
Head Topics ∙ 01/06/2023 ∙ CTSA Program -
Researchers Develop a New Approach to Better Understand the Biology of Polycystic Kidney Disease
News-Medical.net ∙ 01/05/2023 ∙ Tissue Chip -
What Are Leukodystrophies?
CheckRare ∙ 01/04/2023 ∙ RDCRN -
New Technique Provides an Unlimited Supply of Patient-Derived Tissues to Study AMD
AZoLifeSciences.com ∙ 01/03/2023 ∙ 3-D Modeling, Division of Preclinical Innovation -
NIH Researchers Use 3D Bioprinting to Create Eye Tissue
Ophthalmology Times ∙ 01/02/2023 ∙ 3-D Modeling, Division of Preclinical Innovation -
Study Reveals How Chronic Blood Cancer Transitions to Aggressive Disease
innovations-report ∙ 01/02/2023 ∙ CTSA Program -
How Political Partisanship Affects First Impressions
News Brig ∙ 01/02/2023 ∙ CTSA Program -
Polarization Through Perception: How Political Partisanship Affects First Impressions
SciTechDaily ∙ 01/01/2023 ∙ CTSA Program
December 2022
-
New Chip Re-Creates the Human Vagina’s Unique Microbiome
GreekReporter.com ∙ 12/31/2022 ∙ Tissue Chip -
Antidepressant Adherence Among Hispanics: Patients in an Integrated Health Care Model
Black News ∙ 12/30/2022 ∙ CTSA Program -
Drug-Drug Interaction Between Dexamethasone and Direct-Acting Oral Anticoagulants: A Nested Case-Control Study in the National COVID Cohort Collaborative (N3C)
Healthcare Newsdesk ∙ 12/29/2022 ∙ CTSA Program -
Fiscal Year 2023 Omnibus Bill Provides Billions in Federal Funding for Alabama Projects
AmericanTowns.com ∙ 12/28/2022 ∙ CTSA Program -
Families Push Research Forward in Rare Diseases
MedPage Today, LLC ∙ 12/26/2022 ∙ Rare Diseases -
COVID Vaccines Made mRNA a Household Name. How Can It Help in Rare Diseases?
MedPage Today, LLC ∙ 12/26/2022 ∙ Rare Diseases -
When Rural Hospitals Close, Nearby Hospitals Suffer
HealthDay ∙ 12/23/2022 ∙ CTSA Program -
Copy Number Variants as Modifiers of Breast Cancer Risk for BRCA1/BRCA2 Pathogenic Variant Carriers - Communications Biology
Head Topics ∙ 12/22/2022 ∙ CTSA Program -
Machine Learning Approach Detects Brain Tumor Boundaries
Newslanes ∙ 12/16/2022 ∙ CTSA Program -
COVID-19 May Trigger High Antibody Levels With Taste, Smell Changes
Mirage News ∙ 12/15/2022 ∙ CTSA Program -
"Crappy Trials" Are an Innovation Problem
Politico ∙ 12/07/2022 ∙ NCATS -
States’ Push to Legalize Psychedelics Gaining Momentum
Medscape ∙ 12/07/2022 ∙ CTSA Program -
Costs After Cancer Surgery Falling, Medicare Data Show
MedPage Today, LLC ∙ 12/07/2022 ∙ NCATS -
Does Time-Restricted Eating Really Aid Weight Loss
Natural Medicine Journal ∙ 12/06/2022 ∙ CTSA Program -
How Low Should Sample Volume Go?
Drug Discovery News ∙ 12/01/2022 ∙ Division of Preclinical Innovation -
HS Treated in EDs Not Followed Up in Derm Clinics, Study Finds
Medscape ∙ 12/01/2022 ∙ CTSA Program -
The Impact of AI on Drug Discovery
Labroots, Inc. ∙ 12/01/2022 ∙ GARD
November 2022
-
The Bespoke Gene Therapy Consortium
CheckRare ∙ 11/30/2022 ∙ Bespoke Gene Therapy Consortium -
How to Rebuild Brain Cells
Info LiputanDetik ∙ 11/29/2022 ∙ Division of Preclinical Innovation -
Frontiers in Congenital Disorders of Glycosylation Consortium (FCRGC)
CheckRare ∙ 11/17/2022 ∙ RDCRN -
New Study Finds That These Two Diabetes Drugs Perform the Best
SciTechDaily ∙ 11/17/2022 ∙ NCATS -
Pediatric Telehealth Market Report 2022: Launch of School-Based Telehealth Programs Drives Growth
Global Newswire ∙ 11/15/2022 ∙ CTSA Program -
NJSBDC Named as Federal and State Technology (FAST) Award Recipient
New Jersey Business Magazine ∙ 11/14/2022 ∙ SBIR/STIR -
Brain Aging in Black Adults Shows Accelerated Pattern Starting in Midlife
MedPage Today, LLC ∙ 11/14/2022 ∙ CTSA Program -
Previous Breast Cancer Doesn't Increase Poor Pregnancy Outcomes
Medscape ∙ 11/12/2022 ∙ CTSA Program -
Two Studies Link Sserum Vitamin D Levels to Higher Risk of Diabetes in African Americans
Mirage News ∙ 11/11/2022 ∙ NCATS -
The Value of the Rare Diseases Clinical Research Network (RDCRN)
CheckRare ∙ 11/11/2022 ∙ RDCRN -
The NIH Has Given BioRestorative Therapies a Stamp Of Approval
TheNewswire.ca ∙ 11/10/2022 ∙ SBIR/STIR -
Research into Rare Diseases ‘Touches Everyone’
Healthy Debate ∙ 11/09/2022 ∙ RDCRN -
A New Database Helps Predict Effective Drug Combinations
Drug Discovery News ∙ 11/09/2022 ∙ Division of Preclinical Innovation -
AI Supports Clinical Trial for Rare Genetic Disease Treatment
Health IT Analytics ∙ 11/08/2022 ∙ Rare Diseases -
COVID More Severe in Rural Areas
Federal Telemedicine News ∙ 11/07/2022 ∙ CTSA Program -
Patients with Cancer and a Suppressed Immune System Are at High Risk for Severe COVID if Treated with Systemic Drug Therapies, Study Finds
ScienceDaily ∙ 11/03/2022 ∙ CTSA Program -
Certa Therapeutics’ Investigational Drug FT011 Delivers Breakthrough Results as a Potential Novel Treatment for Serious inflammatory and Fibrotic Diseases
BioSpace.com ∙ 11/03/2022 ∙ RDCRN -
Earlier Predictions in COVID-19 Infection Rates With Wearable Device Data and CareEvolution’s Research Platform
Associated Press ∙ 11/02/2022 ∙ CTSA Program -
Latiglutenase Reduces Symptoms in Patients With Celiac Exposed to Gluten
Medscape ∙ 11/02/2022 ∙ CTSA Program -
Bridging the Gap: Finding Treatments for Moderate COVID-19 Disease
Contagion Live ∙ 11/01/2022 ∙ CTSA Program -
Glycan Molecules Are Vital to SARS-CoV-2 Function
Futurity ∙ 11/01/2022 ∙ CTSA Program
October 2022
-
Perceived Discrimination Increased the Risk of Worse Health Outcomes After a Heart Attack
Yahoo! Finance ∙ 10/31/2022 ∙ NCATS -
Study Reveals Racial Disparities in Advanced HF Therapies
Head Topics ∙ 10/25/2022 ∙ NCATS -
Cancer Research Needs Better Databases
Nature ∙ 10/25/2022 ∙ CTSA Program -
Regulatory Support to Accelerate Drug Development Through Translational Medicine
BioSpectrum India ∙ 10/25/2022 ∙ NCATS -
Ivermectin: Still on a Losing Streak as COVID-19 Treatment
MedPage Today, LLC ∙ 10/22/2022 ∙ CTSA Program -
What We Know and Don’t Know About Long COVID
The Hill ∙ 10/20/2022 ∙ NCATS -
NIH Award to Support Informatics-Driven Population Health Research
Health IT Analytics ∙ 10/19/2022 ∙ CTSA Program -
Gender-Affirming Chest Surgeries Increase By Nearly 5x In Teens
TechiLive.in ∙ 10/17/2022 ∙ CTSA Program -
Team Including CWRU Law and Medicine Faculty Awarded of $1.6 Million Grant to Study Ethics of ‘Nudging’ People into Research Participation
Newswise, Inc. ∙ 10/17/2022 ∙ NCATS -
Sonara Health Awarded NIH Funding to Fight the Opioid Crisis
Yahoo! ∙ 10/14/2022 ∙ SBIR/STIR -
Simple Test Could Lead to More Personalised Treatment of Rare Ovarian Cancer
scimex ∙ 10/13/2022 ∙ CTSA Program -
'Disturbing' Lack of Follow-Up Care After Psychiatric Crises
Medscape ∙ 10/13/2022 ∙ CTSA Program -
Vaccine Effectiveness of Primary Series and Booster Doses Against Covid-19 Associated Hospital Admissions in the United States: Living Test Negative D
BFN Today ∙ 10/11/2022 ∙ CTSA Program -
Drug Discovery, Development and Deployment Maps
Pharma Excipients ∙ 10/11/2022 ∙ NCATS -
Coffee Roasting Chemical and Flu Combo Seriously Damages Lungs
Futurity ∙ 10/10/2022 ∙ NCATS -
Bariatric Surgery In NAFLD Tied To Lower Heart Disease Risk
TechiLive.in ∙ 10/07/2022 ∙ NCATS -
Minority Patients Less Likely to Have Amyloid Plaques Necessary for Alzheimer’s Treatments
Nashville Medical News ∙ 10/03/2022 ∙ CTSA Program
September 2022
-
QTc Formula Affects Heart Rhythm Assessment, Chemotherapy Dose
Cancer Therapy Advisor ∙ 09/30/2022 ∙ CTSA Program -
Evaluation of the Sodium Reduction in Communities Program
Global Diaspora News ∙ 09/30/2022 ∙ CTSA Program -
Low-Fat Vs Personalized Diet: Which Is Better For Weight Loss?
TechiLive.in ∙ 09/28/2022 ∙ CTSA Program -
Spectradyne Launches New ARC Particle Analyzer
Drug Development & Delivery ∙ 09/28/2022 ∙ SBIR/STIR -
These Factors Predict Who’ll Live 2, 5, or 10 More Years
Futurity ∙ 09/28/2022 ∙ CTSA Program -
Help Optimize Care for Orphan, Rare Lung Diseases Amid COVID-19 Pandemic
Pharmacy Times ∙ 09/27/2022 ∙ GARD -
Specific N-Glycans Regulate the Development and Functional Maturation of SARS-CoV-2 Spike Protein
News-Medical.net ∙ 09/27/2022 ∙ CTSA Program -
Global Rare Disease Genetic Testing Market to Reach $2.52 Billion by 2030
Yahoo! ∙ 09/26/2022 ∙ RDCRN -
Life Expectancy Tool May Improve Quality of Life for Patients with Dementia
Neuroscience News ∙ 09/26/2022 ∙ CTSA Program -
Antenatal Steroid Therapy for Pregnant Women May Improve Survival Among Extremely Preterm Infants
News-Medical.net ∙ 09/26/2022 ∙ NCATS -
Growing Human Kidneys in a Lab – Scientists Have Made a Significant Breakthrough
SciTechDaily ∙ 09/25/2022 ∙ Tissue Chip -
NIH-Funded Study Shows Sound Sleep Supports Immune Function
PHARMABIZ.com ∙ 09/24/2022 ∙ NCATS -
Investigators at University of Minnesota Report Findings in Insurance (Racial/ethnic Disparities In Postpartum Health Insurance Coverage Among Rural and Urban Us Residents): Insurance
InsuranceNewsNet.com, Inc. ∙ 09/23/2022 ∙ NCATS -
A Consistent Lack of Sleep Negatively Impacts Immune Stem Cells
Technology Networks ∙ 09/22/2022 ∙ CTSA Program -
Getting a Consistent Good Night's Sleep Supports Immune Function, Study Shows
News-Medical.net ∙ 09/21/2022 ∙ CTSA Program -
Two Popular Diabetes Drugs Outperformed Others in Large Clinical Trial
ScienceDaily ∙ 09/21/2022 ∙ CTSA Program -
Tired? Always Cold? Think It’s Hypothyroidism? Think Again
EndocrineWeb ∙ 09/21/2022 ∙ CTSA Program -
Tay-Sachs Disease: What to Know
Medical News Today ∙ 09/20/2022 ∙ GARD -
An EEG Marker of Balance and Cognition in Parkinson’s
Zipe-Education ∙ 09/20/2022 ∙ CTSA Program -
Engaging With Care Teams for Increased Compliance and Adherence in Pulmonary Arterial Hypertension
CheckRare ∙ 09/20/2022 ∙ GARD -
Does Exercise Reduce Risk for Gestational Diabetes?
Medscape ∙ 09/19/2022 ∙ CTSA Program -
The Race to Reinvent the Space Station
Financial Times ∙ 09/18/2022 ∙ Tissue Chip -
Are Meat Sweats a Thing? Causes, Prevention, Treatment and More
MSN ∙ 09/17/2022 ∙ GARD -
CHOP Study Explores the Use of Telemedicine in Child Neurology in Largest Study to Date
Associated Press ∙ 09/16/2022 ∙ CTSA Program -
Inhaled Vasodilator Type Has No Impact on Outcomes
CHEST® Physician ∙ 09/15/2022 ∙ CTSA Program -
Monoclonal Antibody Mepolizumab Reduces Asthma Exacerbations Among Urban Youth: Lancet
https://medicaldialogues.in/pulmonology/news/monoclonal-antibody-mepolizumab-reduces-asthma-exacerbations-among-urban-youth-lancet-98865?infinitescroll=1 ∙ 09/15/2022 ∙ CTSA Program -
COVID-19 Booster Shots Well-Tolerated by Pregnant and Nursing Women
News-Medical.net ∙ 09/14/2022 ∙ CTSA Program -
New Study Supports Safety of COVID-19 Boosters During Pregnancy
Medscape ∙ 09/12/2022 ∙ CTSA Program -
Ketamine Promising for Rare Condition Linked to Autism
Medscape ∙ 09/12/2022 ∙ Biomedical Data Translator -
COVID-19 Jabs and Boosters Are Safe for Pregnant and Lactating People
scimex ∙ 09/09/2022 ∙ CTSA Program -
Biologic Use Varies Between Races in Patients with Asthma
Medscape ∙ 09/08/2022 ∙ CTSA Program -
Business Bulletin Board: Medical Research Grants Awarded; New Swim School in St. Charles
St. Louis Post-Dispatch ∙ 09/07/2022 ∙ CTSA Program -
RETHINC Takes Air Out of COPD-like Therapy for Smokers
Medscape ∙ 09/06/2022 ∙ CTSA Program -
JAMA Neurology Publishes Positive Pivotal Clinical Trial with Vamorolone in Duchenne Muscular Dystrophy
Yahoo! Finance ∙ 09/01/2022 ∙ TRND
August 2022
-
Unruly Hair Syndrome May Be Diagnosed via Genes, Study Indicates
United Press International, Inc. ∙ 08/31/2022 ∙ GARD -
Unruly Hair Syndrome May Be Diagnosed via Genes, Study Indicates
NewsBreak ∙ 08/31/2022 ∙ GARD -
Amgen Announces Positive Data for ABP959, Biosimilar Candidate to Soliris
Pharmacy Times ∙ 08/30/2022 ∙ GARD -
How Have Glucagon Costs Changed in Recent Years?
MedPage Today, LLC ∙ 08/30/2022 ∙ CTSA Program -
NORD Breakthrough Summit 2022: Highly Anticipated Rare Disease Conference Announces Keynote Speakers, Session Topics
Yahoo! Finance ∙ 08/18/2022 ∙ Rare Diseases -
Three Repurposed Drugs Flop for Thwarting Severe COVID
MedPage Today, LLC ∙ 08/17/2022 ∙ CTSA Program -
Gene Mutations from Patients with Debilitating Seizure and Movement Disorder Created in Mice – Newswise
Apex Breaking News Today ∙ 08/15/2022 ∙ CTSA Program -
Three Genetic Mutations Seen in Individuals with KCNMA1-Linked Channelopathy Successfully Mirrored in Mice
News-Medical.net ∙ 08/15/2022 ∙ CTSA Program -
Why Monkeypox Is a Repeat of the Data Mistakes Made with Covid-19
Vox Media, LLC ∙ 08/14/2022 ∙ CTSA Program -
How Science Is Getting Closer to a World Without Animal Testing
Financial Times ∙ 08/14/2022 ∙ SBIR/STIR, Tissue Chip -
Betamethasone Could Improve Outcomes for Prostate Cancer Radiation Therapy
Mirage News ∙ 08/12/2022 ∙ CTSA Program -
Social Determinants of Health Are Important Contributors to Mortality Disparities in U.S., Study Finds
Mirage News ∙ 08/12/2022 ∙ CTSA Program -
Rho Announces Findings from Study it Coordinated to Explore Therapy for Reducing Asthma Attacks Among Disadvantaged Urban Youth
Clinical Research News ∙ 08/11/2022 ∙ CTSA Program -
Study Uses Music to Soothe Dementia Patients and Caregivers
SeniorAu ∙ 08/11/2022 ∙ CTSA Program -
Monoclonal Antibody Decreases Asthma Attacks by 27% in Children and Adolescents of Color
News-Medical.net ∙ 08/10/2022 ∙ CTSA Program -
Better Roadmap for Beating Deadly Leukemia
Mirage News ∙ 08/10/2022 ∙ CTSA Program -
Early Time-Restricted Eating Ups Weight Loss, but Jury Still Out
Medscape ∙ 08/09/2022 ∙ CTSA Program -
Parental Keratoconus Literacy: A Socioeconomic Perspective
New CryptoCurrency News ∙ 08/09/2022 ∙ CTSA Program -
Restricting Eating to Certain Hours Bolsters Weight Loss
TechiLive.in ∙ 08/08/2022 ∙ CTSA Program -
Music Can Benefit People with Alzheimer’s and Caregivers
Futurity ∙ 08/08/2022 ∙ CTSA Program -
Intensity of Football Head Impacts Linked With CTE Risk
MedPage Today, LLC ∙ 08/05/2022 ∙ NCATS -
Hearing Loss Plagues Cancer Survivors No Matter the Type of Chemo
TechiLive.in ∙ 08/04/2022 ∙ CTSA Program -
Mother Says She’s Proud of Toddler’s Uncombable Hair Syndrome
Express Digest ∙ 08/03/2022 ∙ Rare Diseases -
SLFN11's Surveillance Role in Protein Homeostasis
Medical Xpress ∙ 08/03/2022 ∙ Division of Preclinical Innovation -
Exercise Can Improve the Effectiveness of Pancreatic Cancer Treatment
Industry Update ∙ 08/02/2022 ∙ CTSA Program -
Exercise Can Enhance Pancreatic Cancer Treatment
SciTechDaily ∙ 08/02/2022 ∙ CTSA Program -
ISS’s Research on Aging
Federal Telemedicine News ∙ 08/01/2022 ∙ Tissue Chip
July 2022
-
Research Supports Potential of Genome-to-Treatment to Guide Physicians
Mirage News ∙ 07/26/2022 ∙ Division of Preclinical Innovation, GARD -
STRM.BIO Receives $2.1 Million SBIR Grant to Advance Extracellular Vesicle Technology for Non-Viral, In Vivo Delivery of Gene Therapies
NBC12 ∙ 07/26/2022 ∙ SBIR/STIR -
Silent, Subtle and Unseen: How Seizures Happen and Why They're Hard to Diagnose
Yahoo! News ∙ 07/21/2022 ∙ CTSA Program -
Benefits of Physical, Mental Activity on Thinking May Vary for Men and Women, Study Suggests
News-Medical.net ∙ 07/20/2022 ∙ NCATS -
International Space Station National Lab Sponsoring Diverse Set of Experiments on SpaceX CRS-25
West Orlando News ∙ 07/16/2022 ∙ Tissue Chip -
NASA, SpaceX Launch Climate Science Research, More to Space Station
Associated Press ∙ 07/15/2022 ∙ Tissue Chip -
Avrobio Receives Orphan Drug Designation for Hunter Syndrome Gene Therapy
Pharmaceutical Technology ∙ 07/14/2022 ∙ Rare Diseases -
Early Sepsis Control Tied to Lower 90-Day Mortality
MedPage Today, LLC ∙ 07/14/2022 ∙ CTSA Program -
Parents, Community Support Child Stricken With Rare Disorder
The Post-Journal ∙ 07/13/2022 ∙ GARD, Rare Diseases -
Study Shows Convalescent Plasma Does Not Benefit Severely Ill Patients Hospitalized with COVID-19
Chester County Independent (Tennessee) ∙ 07/12/2022 ∙ CTSA Program -
Study Highlights the Multibillion Dollar Burden of Rare Disease
pharmaphorum ∙ 07/11/2022 ∙ Rare Diseases -
NIH-Funded Tissue Chip Investigations to Fly on SpaceX CRS-25 Mission to the ISS
Parabolic Arc ∙ 07/11/2022 ∙ Tissue Chip -
Genetic Variation May Explain Differences in CTE Risk After Repetitive Head Impact
Medscape ∙ 07/11/2022 ∙ CTSA Program -
Children's Book Sold in Port Aransas to Benefit Research on Rare Condition
Corpus Christi Caller Times ∙ 07/11/2022 ∙ GARD -
The Sino-American Pharmaceutical Professionals Association-Greater Philadelphia (SAPA-GP) Hosted the Inaugural @Philly Cell and Gene Therapy Annual Conference
Associated Press ∙ 07/08/2022 ∙ Bespoke Gene Therapy Consortium -
Major Step Forward in Fabricating an Artificial Heart, Fit for a Human
ScienceDaily ∙ 07/08/2022 ∙ Tissue Chip -
NIH-Funded Tissue Chip Investigations to Fly on SpaceX CRS-25 Mission to the ISS
SpaceRef ∙ 07/08/2022 ∙ Tissue Chip
June 2022
-
This Clinical Trial Wanted to End Breast Cancer Disparities. But First It Needed to Enroll Black Women
STAT ∙ 06/30/2022 ∙ CTSA Program -
What is Bjornstad Syndrome?
Archynetys ∙ 06/30/2022 ∙ GARD -
Light During Sleep in Older Adults Linked to Obesity, Diabetes, High Blood Pressure
Mirage News ∙ 06/28/2022 ∙ CTSA Program -
Mixed Bag for Semaglutide in NASH-Related Compensated Cirrhosis
MedPage Today, LLC ∙ 06/27/2022 ∙ NCATS -
Certified Stroke Care Access May Be Reduced for Black Americans
MedPage Today, LLC ∙ 06/27/2022 ∙ CTSA Program -
Modeling a Devastating Childhood Disease on a Chip: Environmental Enteric Dysfunction (EED) Chip Reveals Effects of Nutrition and Genetics on Disease in Children
TechiLive.in ∙ 06/25/2022 ∙ CTSA Program -
Misinformation Will Be Rampant When It Comes to COVID-19 Shots for Young Children – Here's What You Can Do to Counter It
Yahoo! News ∙ 06/24/2022 ∙ CTSA Program -
NCATS’ “Many-Diseases-at-a-Time” Approach to Gene Therapy
CheckRare ∙ 06/24/2022 ∙ Rare Diseases -
Creating a Safe Space for IoT
Federal News Network ∙ 06/21/2022 ∙ NCATS -
Immune Modulator Drugs Improved Survival for People Hospitalized with COVID-19
POZ ∙ 06/21/2022 ∙ CTSA Program -
Denver Nurse Turns Patient, Learns from Being on the Receiving End of Caregiving
KDVR ∙ 06/19/2022 ∙ GARD -
Miracle Pill Paxlovid Benched as the People’s Antivirals Ivermectin & Tollovid Sub In
ZeroHedge.com/ABC Media, Ltd. ∙ 06/17/2022 ∙ CTSA Program -
Has the COVID-19 Pandemic Impacted Flu Shot Uptake?
Precision Vaccinations ∙ 06/17/2022 ∙ CTSA Program -
Sensor-Equipped Computer Program Tracks the Patients’ Arm Movements During Stroke Rehabilitation
Newspages.co.za ∙ 06/17/2022 ∙ CTSA Program -
UCLA Study Finds Factors Causing Low COVID-19 Vaccination Rates Have Spilled Over to Lower Flu Vaccination Rates
Sierra Sun Times ∙ 06/17/2022 ∙ CTSA Program -
Sensor-Equipped Computer Program Tracks the Patients' Arm Movements During Stroke Rehabilitation
News-Medical.net ∙ 06/16/2022 ∙ CTSA Program -
Synthetic Opioid Use Up Almost 800% Nationwide
Medscape ∙ 06/15/2022 ∙ CTSA Program -
Factors Causing Low COVID-19 Vaccination Have Spilled Over to Lower Flu Vaccination Rates, Study Finds
ScienceDaily ∙ 06/15/2022 ∙ CTSA Program -
VA Adds Nine Rare Cancers to Presumed Service-Connected Disabilities
U.S. Medicine ∙ 06/12/2022 ∙ GARD, Rare Diseases -
Characteristics of Long COVID
RT Magazine ∙ 06/10/2022 ∙ CTSA Program -
Santhera and ReveraGen to Present New Data with Vamorolone at 2022 Parent Project Muscular Dystrophy Conference
Yahoo! Finance ∙ 06/09/2022 ∙ NCATS -
How Might Chimeric, Droplet-Forming Proteins Contribute to Cancer?
Nation World News ∙ 06/06/2022 ∙ NCATS -
OSU Studies: Third Booster Provides Strong Protection against Variants
The Daily Legal News ∙ 06/06/2022 ∙ NCATS -
Immune Modulator Drugs Improved Survival for People Hospitalized with Covid
Mirage News ∙ 06/03/2022 ∙ NCATS -
Hillstream BioPharma Provides Corporate Update
Yahoo! Finance ∙ 06/02/2022 ∙ NCATS -
Bristol Myers Squibb Announces Topline Results Showing Treatment with Orencia (abatacept) Improved Survival in People Hospitalized with COVID-19
Associated Press ∙ 06/02/2022 ∙ CTSA Program -
Q&A: Machine Learning Models Identify Patients with Long COVID
Healio ∙ 06/01/2022 ∙ CTSA Program -
Unnecessary Antibiotics Do Kids More Harm than Good
Futurity ∙ 06/01/2022 ∙ CTSA Program
May 2022
-
Serum Pepsinogen Is Associated with Gastric Cancer Risk
MDedge Hematology and Oncology ∙ 05/22/2022 ∙ CTSA Program -
NIH Announces Antiviral Drug Development Awards
PHARMABIZ.com ∙ 05/20/2022 ∙ Division of Preclinical Innovation -
MELD Scoring for Liver Transplants in Need of Sex Adjustment, Study Says
TechiLive.in ∙ 05/19/2022 ∙ CTSA Program -
COVID Booster Needed for Broad Protection against Omicron Variants
ScienceDaily ∙ 05/18/2022 ∙ CTSA Program -
NIH Awards $577 Million to Establish AViDD Centers for Pathogens of Pandemic Concern
News-Medical.net ∙ 05/18/2022 ∙ Division of Preclinical Innovation -
2022 FedHealthIT Innovation Award Winners
FedHealthIT ∙ 05/17/2022 ∙ NCATS -
Scientists Identify Characteristics to Better Define Long COVID: Using Machine Learning, Researchers Find Patterns in Electronic Health Record Data to Better Identify Those Likely to Have the Condition
TechiLive.in ∙ 05/17/2022 ∙ CTSA Program -
Widely Available AI Could Have Deadly Consequences
WIRED ∙ 05/17/2022 ∙ Division of Preclinical Innovation -
HAIP Chemotherapy or Resection for Multifocal Bile Duct Cancer?
TechiLive.in ∙ 05/12/2022 ∙ NCATS -
Do COVID Vaccines Stave Off New Medical Conditions?
TechiLive.in ∙ 05/10/2022 ∙ CTSA Program -
Here are Federal Agencies' Steps to IOT Adoption
GovernmentCIO Media & Research ∙ 05/09/2022 ∙ NCATS -
Use Case Show Translator’s Potential to Expedite Clinical Research
RENCI ∙ 05/04/2022 ∙ Biomedical Data Translator -
Unlocking the Potential of Health Data to Help Research and Treatments
Nature ∙ 05/03/2022 ∙ CTSA Program
April 2022
-
Insulin Spray Improved Gait, Cognitive Function in Patients with and without Type 2 Diabetes, Clinical Trial Shows
Mirage News ∙ 04/30/2022 ∙ CTSA Program -
Ridner Concludes Five-Year, Multi-Site Trial to Assess Lymphedema Prevention
Mirage News ∙ 04/29/2022 ∙ CTSA Program -
Researchers Test the Power of Machine Learning to Unravel Long Covid’s Mysteries
STAT ∙ 04/29/2022 ∙ CTSA Program -
Synthetic Data Accurately Replicates the Results of Analyses from Real COVID-19 Patient Data
News-Medical.net ∙ 04/27/2022 ∙ CTSA Program -
EPA Posts Presentations from Meeting on New Chemicals Collaborative Research Program
The National Law Review ∙ 04/27/2022 ∙ Division of Preclinical Innovation -
Team Wins Global Competition to Develop Next-Gen Tools, Improve Public Health Solutions
Mirage News ∙ 04/26/2022 ∙ NCATS -
Hydrocortisone Ineffective against Bronchopulmonary Dysplasia in Extremely Preterm Infants
RT Magazine ∙ 04/26/2022 ∙ CTSA Program -
Panel Discussion: The High Cost of Rare Diseases
MasupMD ∙ 04/25/2022 ∙ Rare Diseases -
EPA Holds Meeting on TSCA New Chemicals Collaborative Research Program
The National Law Review ∙ 04/22/2022 ∙ Division of Preclinical Innovation
-
Virpax Pharmaceuticals Reports 2022 Year-End Results
-